NCT07262970 2025-12-04Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a TumorRezoluteAvailable
NCT02779257 2022-03-04Pasireotide Treatment for Neuroendocrine TumorUniversity of Maryland, BaltimorePhase 4 Withdrawn